Who
Stefano Buono
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, newcleo; Director, Abeona Therapeutics.
In numbers
- Trades disclosed
- 17
- Buys
- 3
- Sells
- 0
- Bought
- $1.0M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 22 May 2018
- Last trade
- 21 Sep 2026
- Last filed
- 23 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —134,596 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —4,291 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —9,814 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —134,596 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —4,291 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —9,814 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —11,960 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —1,921,029 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —11,960 at $0.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | NWCL newcleooption or derivative · Machinery | SEC FORM 4 Code A | —1,921,029 at $0.00 | filing |
| 20 May 2020filed 22 May 2020 | ABEO Abeona Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,518 at $0.00 | filing |
| 20 May 2020filed 22 May 2020 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —17,969 at $0.00 | filing |
| 24 Dec 2019filed 31 Dec 2019 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Bought | $500K200,000 at $2.50 | filing |
| 21 May 2019filed 23 May 2019 | ABEO Abeona Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,827 at $0.00 | filing |
| 11 Apr 2019filed 12 Apr 2019 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Bought | $388K49,020 at $7.91 | filing |
| 10 Apr 2019filed 12 Apr 2019 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Bought | $158K20,980 at $7.54 | filing |
| 22 May 2018filed 23 May 2018 | ABEO Abeona Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.